Diabetes Abciximab Stent Evaluation - DANTE

Description:

The goal of the trial was to evaluate if abciximab given at the time of stent implantation would be associated with reductions in in-stent intimal hyperplasia measured by intravascular ultrasound at 6-month follow-up in patients with type 2 diabetes.